Nicotine Delivery and User Ratings of IQOS Heated Tobacco System Compared With Cigarettes, Juul, and Refillable E-Cigarettes.
Journal
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751
Informations de publication
Date de publication:
07 10 2021
07 10 2021
Historique:
received:
07
12
2020
accepted:
11
05
2021
pubmed:
14
5
2021
medline:
25
11
2021
entrez:
13
5
2021
Statut:
ppublish
Résumé
Reduced-risk nicotine products are more likely to replace smoking if they match cigarettes in nicotine delivery and user satisfaction. We examined the nicotine delivery profile and user ratings of IQOS heated tobacco system and compared it with own brand cigarettes (OBC), Juul, and refillable e-cigarettes (EC).Participants (N = 22) who were daily vapers smoking <1 cigarette per day on average, attended after overnight abstinence from smoking and vaping, to test at separate sessions OBC, IQOS, and Juul. Eight participants also tested two refillable EC using e-liquid with 20 mg/mL nicotine. At each session, a baseline blood sample was taken before participants used the product ad libitum for 5 minutes. Further samples were taken at 2, 4, 6, 8, 10, and 30 minutes. Maximum nicotine concentration (Cmax), time to Cmax (Tmax), and nicotine delivered over 30 minutes (AUC0->30) were calculated. Participants rated their urge to smoke and product characteristics. IQOS delivered less nicotine than OBC (AUC0->30: z = -2.73, p = .006), and than Juul (AUC0->30: z = -3.08, p = .002; Cmax: z = -2.65, p = .008), and received less favorable ratings than Juul (effect on urges to smoke: z = -3.23, p = .001; speed of urge relief: z = -2.75, p = .006; recommendation to friends: z = -2.45, p = .014). Compared with refillable EC, IQOS delivered nicotine faster (Tmax: z = -2.37, p = .018), but received less favorable overall ratings (recommended to friends: z = -2.32, p = .021). IQOS' pharmacokinetic profile suggests that it may be less effective than Juul for smoking cessation, but at least as effective as refillable EC; although participants, who were experienced vapers rather than IQOS users, preferred refillable EC. Because IQOS provided less efficient nicotine delivery than cigarettes and Juul in this sample, and also had a weaker effect on urges to smoke than Juul, it could be less helpful than Juul in assisting such dual users, and possibly smokers generally, to switch to an alternative product. IQOS, however, provided nicotine faster than refillable EC products, although participants preferred EC.
Identifiants
pubmed: 33983450
pii: 6275288
doi: 10.1093/ntr/ntab094
pmc: PMC8496472
doi:
Substances chimiques
Nicotine
6M3C89ZY6R
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1889-1894Subventions
Organisme : Cancer Research UK
ID : C49913/A25756
Pays : United Kingdom
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.
Références
Regul Toxicol Pharmacol. 2016 Nov 30;81 Suppl 2:S48-S58
pubmed: 27793747
Nicotine Tob Res. 2015 Feb;17(2):175-9
pubmed: 25122503
Nicotine Tob Res. 2016 May;18(5):1134-41
pubmed: 26045250
Sci Rep. 2015 Jun 17;5:11269
pubmed: 26082330
J Hazard Mater. 2021 Jan 5;401:123417
pubmed: 32763707
Exp Clin Psychopharmacol. 2017 Oct;25(5):380-392
pubmed: 29048187
Tob Control. 2020 Feb 10;:
pubmed: 32041833
Drug Alcohol Depend. 2007 Jul 10;89(2-3):302-5
pubmed: 17320313
Tob Control. 2020 Jul;29(4):381-387
pubmed: 31209129
PLoS One. 2018 Apr 25;13(4):e0195896
pubmed: 29694428
Psychopharmacology (Berl). 2017 Mar;234(5):773-779
pubmed: 28070620
Regul Toxicol Pharmacol. 2016 Nov 30;81 Suppl 2:S27-S47
pubmed: 27720919
Nicotine Tob Res. 2018 Jul 9;20(8):1004-1009
pubmed: 28637344
Addiction. 2020 Jun;115(6):1141-1148
pubmed: 31994254
Psychopharmacology (Berl). 2018 Apr;235(4):1083-1092
pubmed: 29306962
JAMA Intern Med. 2017 Jul 1;177(7):1050-1052
pubmed: 28531246
Nicotine Tob Res. 2019 Aug 19;21(9):1285-1288
pubmed: 30476301
Comput Methods Programs Biomed. 2010 Sep;99(3):306-14
pubmed: 20176408
Tob Control. 2018 Nov;27(Suppl 1):s13-s19
pubmed: 30206183
Regul Toxicol Pharmacol. 2017 Oct;89:193-199
pubmed: 28760390
J UOEH. 2017;39(3):201-207
pubmed: 28904270
Nicotine Tob Res. 2020 Jun 12;22(7):1077-1085
pubmed: 31641752